Articles Tagged With:
-
Rapid Screening for Future Risk of Parkinson’s Disease Dementia
The Montreal Parkinson Risk of Dementia Scale provides a simple eight-item screening tool with high predictive value for developing Parkinson’s disease dementia.
-
Combined Treatments with Medications for Hypertension and Hyperlipidemia Dramatically Reduce the Risk of Stroke
In this real-world study, fixed-dose candesartan/hydrochlorothiazide combined with low-dose rosuvastatin reduced first stroke by 44% in patients at intermediate risk of cardiovascular disease and was well tolerated, with minimum dropout of patients.
-
Chiropractic Spinal Manipulation for Migraine
Chiropractic spinal manipulation offers no benefit over placebo for migraineurs.
-
The Pulmonary Embolism Rule-out Criteria in Low-risk Patients
A cluster randomized trial of the pulmonary embolism rule-out criteria (PERC) compared to usual care for patients estimated to be at low risk of pulmonary embolus (PE) in EDs showed that PERC was non-inferior to usual care at identifying patients who would be free of symptomatic PE at three months, resulting in less use of healthcare resources.
-
With Funding Announcement, Trump Begins Reshaping Title X
Funding announcement to reshape Title X.
-
What’s Your Approach to Abnormal Uterine Bleeding?
Statistics indicate that one-third of outpatient gynecologist visits are for abnormal uterine bleeding, with the condition accounting for more than 70% of gynecologic consultations in the perimenopausal and postmenopausal years.
-
Research Examines Self-administered DMPA
New research indicates that use of subcutaneous depot medroxyprogesterone (DMPA-SC, marketed as Sayana Press, Pfizer Inc.) may help women to continue using injectable contraception longer than women who receive traditional intramuscular injections.
-
Push Is on to Combat Drug-resistant Gonorrhea
In a recently released study, Centers for Disease Control and Prevention (CDC) researchers report that while 81% of patients diagnosed with gonorrhea were treated using dual therapy, nearly one in five were treated with a different regimen.
-
FDA Issues Restrictions for Sterilization Option
The Food and Drug Administration has issued new restrictions regarding the sale and distribution of the permanent contraceptive device, Essure.
-
Check Your Clinical Practice for LARC Methods
The American College of Obstetricians and Gynecologists now recognizes immediate postpartum placement of either the intrauterine device or the contraceptive implant as a best practice because of the long-acting reversible contraceptive methods’ role in preventing rapid repeat and unintended pregnancy